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Abstract
Current methods of generating rat induced pluripotent stem cells are based on viral transduction of pluripotency inducing
genes (Oct4, Sox2, c-myc and Klf4) into somatic cells. These activate endogenous pluripotency genes and reprogram the
identity of the cell to an undifferentiated state. Epigenetic silencing of exogenous genes has to occur to allow normal iPS
cell differentiation. To gain more control over the expression of exogenous reprogramming factors, we used a novel
doxycycline-inducible plasmid vector encoding Oct4, Sox2, c-Myc and Klf4. To ensure efficient and controlled generation of
iPS cells by plasmid transfection we equipped the reprogramming vector with a bacteriophage wC31 attB site and used a
wC31 integrase expression vector to enhance vector integration. A series of doxycycline-independent rat iPS cell lines were
established. These were characterized by immunocytochemical detection of Oct4, SSEA1 and SSEA4, alkaline phosphatase
staining, methylation analysis of the endogenous Oct4 promoter and RT-PCR analysis of endogenous rat pluripotency
genes. We also determined the number of vector integrations and the extent to which reprogramming factor gene
expression was controlled. Protocols were developed to generate embryoid bodies and rat iPS cells demonstrated as
pluripotent by generating derivatives of all three embryonic germ layers in vitro, and teratoma formation in vivo. All data
suggest that our rat iPS cells, generated by plasmid based reprogramming, are similar to rat ES cells. Methods of DNA
transfection, protein transduction and feeder-free monolayer culture of rat iPS cells were established to enable future
applications.
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Introduction
The rat has long been an invaluable animal model in many
biomedical research fields, including behavioral studies, cardio-
vascular disease, immunology, transplantation, toxicology and
pharmacology [1], [2], [3], [4]. However the use of rats has been
hindered by the lack of embryonic stem (ES) cells and the
consequent difficulty in generating animals with precise genetic
modifications. Derivation of germline competent rat ES cells [5],
[6] and their functional equivalent, induced pluripotent stem cells
[7], [8] thus represents a major step forward.
Induced pluripotent stem (iPS) cells can be derived from somatic
cells by forced expression of exogenous transcription factors,
notably Oct4, Sox2, c-Myc and Klf4 [9]. These activate
endogenous pluripotency genes and reprogram the cell to a
pluripotent state. ES and iPS cells have now enabled the
generation of rats with gene targeted inactivation of p53,
protease-activated receptor-2 and hypoxanthine phosphoribosyl-
transferase [10], [11], [12], [13]. Directed differentiation of rat
pluripotent stem cells also provides a source of cell types such as
cardiomyocytes [14], which are useful for toxicological screening,
research into tissue regeneration and development of organ repair
procedures.
Rat iPS cell lines have been derived from different rat strains
and a variety of somatic cells, including embryonic fibroblasts,
neural precursor cells, bone marrow cells, liver progenitor cells,
and ear fibroblasts [8], [7], [15], [16]. However this work has been
based on retroviral or lentiviral vectors that have drawbacks.
Establishment of a true self-sustaining pluripotent state, indepen-
dent of exogenous reprogramming factor expression, requires
epigenetic silencing of the exogenous genes. Virally transduced
genes are frequently silenced in the host cell, but persistence or
reactivation of factor expression interferes with differentiation, and
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c-Myc expression has led to tumor formation in iPS derived
offspring in mice [17]. Next generation iPS cells must therefore
incorporate tight control of transgene expression. The limited
capacity of retroviral vectors also means that individual retrovi-
ruses are commonly used to introduce reprogramming factors.
Multiple independent infections of each cell are thus required to
deliver the full complement of factors and many cells may not
receive an ideal, equimolar ratio of each gene [18].
Here we report iPS cell generation using a non-viral vector
containing the murine reprogramming factors Oct4, Sox2, c-Myc
and Klf4 controlled by a bidirectional doxycycline-inducible
promoter.
Materials and Methods
Animal experiments were approved by the Government of
Upper Bavaria and performed according to the German Animal
Welfare Act and European Union Normative for Care and Use of
Experimental Animals (permit number: Az. 209.1/211-2531-114-
03). Chemicals were obtained from Sigma Aldrich, and cell culture
media and supplements from PAA Laboratories or Gibco Life
Technologies unless otherwise specified. Oligonucleotide sequenc-
es are shown in Tables S1, S2, S3.
Figure 1. Generation and analysis of iPS cells. (A) Schematic representation of the reprogramming vector pReproII-attB and the wC31 integrase
expression plasmid pCAG-C31Int(NLS). Indicated are the four transcription factors Oct4, Sox2, c-Myc and Klf4 linked by T2A peptides, the bidirectional
doxycycline-inducible promoter Pbi-1, consisting of two copies of the minimal CMV promoter linked by a tet-responsive element (TRE), the expression
cassette for the reverse tetracycline controlled transactivator rtTA2(S)-M2 and the tet repressor-KRAB fusion protein tTSKRAB linked by an internal
ribosome entry site (IRES), the chicken beta-actin enhancer/promoter (CAG) and the attB site. The plasmid pCAG-C31Int(NLS) contains a constitutive
expression cassette for the wC31 integrase under the control of the CAG promoter. (B) Time line of rat iPS cell generation. DOX: doxycycline, d: day.
(C) Southern blot analysis of four doxycycline-dependent rat iPS cell lines. A Klf4 probe was used that detects two endogenous fragments (Endo) in
source cells rADMSC (rAD) and rEF as well as exogenous Klf4 (Exo) in iPS cell lines. (D) PCR analysis of rat pseudo-attP sites in lines T1, T13, E9 and E14.
Primers flanking known rat pseudo-attP sites (rps1F/R, rps2F/R, rps3F/R) were combined with a primer binding in pReproII-attB (ReB). Rat EF, ADMSC
(AD) and water (W) were used as negative controls.
doi:10.1371/journal.pone.0055170.g001
Rat iPS Cells without Viral Vectors
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Plasmids
The reprogramming cassette of pReproII-attB was assembled
by standard cloning and PCR methods using the Pbi-1 promoter
from pBI-5 (Clontech) and cDNAs for murine Oct4, Sox2, Klf4
and c-Myc (ImaGenes). Two coding regions, linked by a T2A
peptide sequence [19], [20], were placed on either side of the Pbi-1
promoter. Each bicistronic coding region (Oct4-T2A-c-Myc or
Sox2-T2A-Klf4) is preceded by a hybrid intron [21] and
terminated by the bovine growth hormone (bGH) polyadenylation
signal. The reprogramming unit was combined with a CAG
(cytomegalovirus early enhancer element and chicken beta-actin
promoter) promoter driven expression cassette for rtTA2(S)-M2
and tTSKRAB from plasmid pRTS-1 [22], in which the Em
enhancer was replaced by the cytomegalovirus early enhancer. A
synthetic DNA element containing a 53 bp attB site, which can be
recognized by wC31 integrase, was added to generate pReproII-
attB. The wC31 integrase expression plasmid pCAG-C31Int(NLS)
has been described previously [23].
Generation of Rat iPS Cells
Adipose tissue-derived mesenchymal stem cells (rADMSC) were
isolated from subcutaneous fat, and fibroblasts from ear tissue
(rEFs) of Fischer and Wistar rats according to standard methods.
The passage number of the source cells was between P2 and P3,
both showed typical fibroblast-like morphology. For the genera-
tion of iPS cells, 56105 rADMSCs were nucleofected with 1 mg
reprogramming vector pReproII-attB and 1 mg wC31 integrase
expression vector pCAG-C31Int(NLS) (see Figure 1A) using the
Nucleofector II device (Lonza) with program U-023 and the
Human MSC Nucleofector Kit (Lonza). 56105 rEFs were
nucleofected with 3 mg pReproII-attB and 3 mg pCAG-
C31Int(NLS) using program A-024 and the Basic Nucleofector
Kit for Primary Mammalian Fibroblasts (Lonza). Cells were plated
onto tissue culture flasks on day 0 and nucleofection repeated on
day 3. Transfected cells were transferred onto mitomycin C
inactivated mouse embryonic fibroblasts (MEFs) on day 6. A
schematic overview is shown in Figure 1B. Rat iPS cells were
derived in two different media. N2B27-3i medium: 1:1 mixture of
N2 medium (DMEM/F12, 16N2 supplement, 100 mg/ml BSA
fraction V) and B27 medium (Neurobasal medium, 16B27
supplement w/o retinoic acid, 2 mM Glutamax) supplemented
with 0.1 mM 2-mercaptoethanol, 20% Knockout Serum Replace-
ment, 1000 U/ml hLIF (produced in house), 3 mM GSK3b
inhibitor CHIR99021 (Axon Medchem), 0.5 mM MEK1/2
inhibitor PD0325901 (Axon Medchem), 0.5 mM ALK5 inhibitor
A83-01 (Biotrend). N2B27-2i medium: 1:1 mixture of N2 medium
and B27 medium (see above) supplemented with 0.1 mM 2-
mercaptoethanol, 1000 U/ml hLIF, 3 mM GSK3b inhibitor
CHIR99021, 0.5 mM MEK1/2 inhibitor PD0325901. Doxycy-
cline (1.5 mg/ml) was added to culture media to induce expression
of reprogramming factors.
General Cell Culture
Rat adipose tissue-derived mesenchymal stem cells (rADMSC)
were cultured in MSC medium (MEM a, 10% FCS). Rat ear
fibroblasts (rEF) were cultured in EF medium (DMEM, 15% FCS,
16 non-essential amino acids, 16 sodium pyruvate, 2 mM
Glutamax, 5 ng/ml bFGF (Promokine)). Mouse embryonic
fibroblasts (MEF) were cultured in DMEM+ medium (DMEM,
10% FCS, 16 non-essential amino acids, 2 mM Glutamax, 16
sodium pyruvate). Rat iPS cells were maintained on mitomycin C
inactivated MEFs in N2B27-2i or N2B27-3i medium. iPS cells
were routinely subcultured every 3 to 4 days by flushing loosely
attached colonies off the feeder layer and dissociation by Accutase
in suspension. For feeder-free monolayer culture, plates were
coated with either 0.1% gelatin from bovine skin in PBS, 5 mg/ml
fibronectin in PBS, 200 mg/ml rat tail collagen type I (Serva) in
H2O, 2% growth factor reduced Matrigel (BD Biosciences) in
DMEM/F12, 2% Geltrex (Invitrogen) in DMEM/F12 or 4.2 mg/
ml laminin (Roche) in PBS for 2 h at 37uC.
Isolation of Genomic DNA and RNA
Genomic DNA for bisulfite sequencing and PCR was isolated
using the GenElute Mammalian Genomic DNA Miniprep Kit
(Sigma). DNA for Southern blot analysis was obtained by standard
phenol/chloroform extraction. RNA was isolated using either
Trizol (Invitrogen), or the High Pure RNA Isolation Kit (Roche),
and genomic DNA removed by treatment with the Turbo DNA-
free Kit (Ambion) according to the manufacturer’s instructions.
RT-PCR
RNA was reverse transcribed with random hexamer oligonu-
cleotides using SuperScript III (Invitrogen) according to the
manufacturer’s protocol. PCR with GoTaq DNA polymerase
(Promega) was performed using oligonucleotides listed in Table
S1. Thermal cycling conditions were: 94uC, 2 min; 30 cycles of
94uC for 30 s, 58uC for 30 s, 72uC for 1 min; then final elongation
72uC for 5 min. Quantitative PCR was performed using a 7500
Fast Real-Time PCR System and the SYBR Green PCR Master
Mix (Applied Biosystems) with oligonucleotides listed in Table S1,
according to the manufacturer’s instructions. Thermal cycling
conditions were: 95uC, 10 min; 40 cycles of 95uC for 15 s, 60uC
for 1 min. Expression of the exogenous reprogramming factors
was calculated with the DDCT method and expressed as fold
change relative to the corresponding cell line with doxycycline
induction.
Southern Blot Analysis
10 mg genomic DNA was digested with BglII, separated by gel
electrophoresis and transferred to Hybond-N+ membrane by
capillary blotting. The hybridization probe was generated by PCR
with GoTaq DNA polymerase (Promega) incorporating alkali-
labile digoxigenin-11-dUTP (Roche). The 1308 bp Klf4 probe was
amplified from pReproII-attB with primers prKlf4_F and
prKlf4_R (see Table S3). Thermal cycling conditions were:
94uC, 2 min; 35 cycles of 94uC for 30 s, 58uC for 30 s, 72uC for
90 s; then final elongation 72uC for 5 min. Hybridization using
DIG Easy Hyb (Roche) and probe detection using anti-
digoxigenin antibody Fab fragments conjugated with alkaline
phosphatase (Roche) were performed according to the manufac-
turer’s instructions.
PCR for Pseudo-attP Sites
Pseudo-attP site PCR analysis was performed as described [24]
using published oligonucleotides for rat pseudo-attP sites rps1, rps2
Table 1. Doxycyline-dependent rat iPS cell lines.
Rat strain Cell type Isolated colonies Established lines Efficiency
Fischer334 rADMSC 129 21 16.2%
Fischer334 rEF 73 16 21.9%
Wistar rADMSC* 17 7 41.1%
Wistar rEF 96 11 11.4%
*Established in N2B27/2i medium instead of N2B27/3i.
doi:10.1371/journal.pone.0055170.t001
Rat iPS Cells without Viral Vectors
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and rps3 (see Table S2). Each PCR assay used one primer within
the reprogramming vector and one primer in the genomic DNA
sequence upstream or downstream of rps1, 2 or 3 sites. PCR was
performed with GoTaq DNA polymerase (Promega) according to
the manufacturer’s instructions. Thermal cycling conditions were:
94uC, 2 min; 35 cycles of 94uC for 30 s, 58uC for 30 s, 72uC for
2 min; then final elongation 72uC for 5 min. PCR products from
rat iPS cell lines T1 and T13 were subcloned into pJet1.2/blunt
(Fermentas) and the DNA sequence determined.
Alkaline Phosphatase and Immunocytochemistry
Cells were fixed with 4% paraformaldehyde. Alkaline phospha-
tase staining was performed with SIGMAFAST BCIP/NBT
according to the manufacturer’s instructions. Immunocytochem-
istry of undifferentiated and differentiated iPS cells was performed
with primary antibodies against Oct4 (1:100; sc-8628, Santa
Cruz), SSEA1 (1:200; sc-21702, Santa Cruz), SSEA4 (1:100; sc-
21704, Santa Cruz), albumin (1:100; A0001, Dako), sarcomeric a-
actinin (1:250; EA-53, Sigma) or bIII-tubulin (1:250; SDL.3D10,
Sigma) followed by goat anti-mouse IgM-FITC (1:200; sc-2082,
Santa Cruz), chicken anti-goat IgG-FITC (1:200; sc-2988, Santa
cruz), goat anti-mouse IgG-FITC (1:200; sc-2010, Santa Cruz),
Alexa Fluor 594 goat anti-rabbit IgG (1:750; A11012, Invitrogen)
secondary antibodies. Nuclei were stained with Hoechst 33258.
Bisulfite Sequencing
500 ng genomic DNA was treated with the Epitect Bisulfite Kit
(Qiagen) or Epimark Bisulfite Conversion Kit (NEB) according to
the manufacturer’s instructions. A 206 bp region of the endoge-
nous rat Oct4 promoter (21495 to 21290) was amplified by PCR
from bisulfite converted genomic DNA using primers BS-Oct4_F
and BS-Oct4_R [8] (see Table S3). PCR was performed with
GoTaq DNA polymerase (Promega). Thermal cycling conditions
were: 94uC, 2 min; 35 cycles of 94uC for 30 s, 55uC for 30 s, 72uC
for 1 min; then final elongation 72uC for 5 min. PCR fragments
were subcloned into the vector pJet1.2/blunt (Fermentas) and the
DNA sequence of five individual clones determined. Bisulfite
sequencing data were analyzed with the online tool QUMA [25].
Karyotype Analysis
Rat iPS cells in log phase were treated with 10 mg/ml colcemid
for 4 h. Cells were collected, treated with Accutase to obtain a
single cell suspension, incubated for 12 min at room temperature
in 75 mM KCl and fixed with ice cold methanol/acetic acid (3:1).
Metaphase preparation and chromosome counting was performed
by CHROMBios GmbH (Nussdorf, Germany).
Embryoid Body (EB) Formation
Embryoid bodies were generated either by growth in suspen-
sion, or ‘‘colony EB’’ culture. For suspension culture, iPS cells
were dissociated with Accutase, resuspended at 46106 cells per
15 ml EB medium I (50% N2B27-2i, 50% DMEM+) and cultured
in 10 cm non-adhesive culture dishes. For colony EB culture,
loosely attached iPS colonies were flushed off the feeder layer and
transferred into 10 cm non-adhesive culture dishes in EB medium
I. For both methods, the medium was changed to EB medium II
(30% N2B27-2i, 70% DMEM+) after 48 h. A further 48 h later,
medium was changed to DMEM+ and EBs cultured for an
additional 4 days in non-adhesive culture dishes. After 8 days EBs
were analyzed or allowed to attach to gelatin-coated tissue culture
plates in DMEM+ medium.
Teratoma Formation
4–56106 rat iPS cells from line T1/64 were resuspended in
N2B27-2i, mixed with high density Matrigel (BD Bioscience) and
injected subcutaneously into NOD scid gamma (NSG) mice.
Teratomas were harvested after 25 days, fixed in 4% paraformal-
dehyde, embedded in paraffin and sectioned. Sections were
stained with hematoxylin and eosin (H&E) according to standard
protocols.
Transfection of Rat iPS Cells
Rat iPS cells were transfected with Nanofectin (PAA), or
Lipofectamine 2000 (Invitrogen) as monolayer cultures on 2%
Geltrex (Invitrogen) in 12 well plates according to the manufac-
turer’s instructions using the GFP expression plasmid pmaxGFP
(Lonza). Nucleofection was performed using the Nucleofector II
device (Lonza) and the Mouse Embryonic Stem Cell Kit (Lonza)
with program A-024 according to the manufacturer’s instructions.
Production of Recombinant NLS-Cherry-9R Protein and
Protein Transduction
The expression vector pTriEx-Cherry encodes the red fluores-
cent protein NLS-Cherry-9R. NLS-Cherry-9R contains a 6xHis
tag, the SV40 Large-T nuclear localization signal (NLS) at the N-
terminus and a protein transduction domain consisting of 9
arginine residues (9R) at the C-terminus of the mCherry red
fluorescent protein. The pTriEx-Cherry expression cassette was
assembled by standard PCR methods. Recognition sites for the
restriction enzyme BspHI and XhoI, the 6xHis tag, NLS sequence
and 9R were added to the mCherry fluorescent reporter gene
Figure 2. Analysis of doxycycline-independent rat iPS cell lines. (A) Morphology of somatic cell types used to generate rat iPS cells (rADMSC,
rEF) and typical spheroidal morphology of doxycycline-independent iPS cell lines T1/64 and E9/54 on feeder cells (106 magnification). (B)
Immunocytochemical and alkaline phosphatase staining of iPS lines T1/64 and E9/54 and rADMSC (106 and 56magnification). (C) Methylation
analysis of rat Oct4 promoter region (21495 to 21290) in source cells rADMSC, rEF and iPS lines T1/64 and E9/54. Circles indicate CpG methylation
sites, dark shading represents methylated and open shading non-methylated. (D) Quantitative RT-PCR analysis of exogenous reprogramming factor
expression. Fold change in bicistronic mRNA detected in doxycycline-independent (T1/64, T13/3, E9/19, E9/54, E14/5, E14/15) iPS cells is shown
relative to each parental doxycycline-dependent line (T1, T13, E9, E14) as indicated. Left: Oct4-T2A-c-Myc bicistronic fragment. Right: Sox2-T2A-Klf4
bicistronic fragment. Data was normalized to GAPDH expression. (E) Expression analysis of endogenous pluripotency factors Oct4, Sox2, Nanog, FGF4
and Rex1 in somatic source cells rADMSC (rAD) and rEF and doxycycline-independent iPS cell lines T1/64 and E9/54. GAPDH control, water (W),
reprogramming vector and reverse transcriptase enzyme (-RT) negative controls are indicated.
doi:10.1371/journal.pone.0055170.g002
Table 2. Doxycycline-independent rat iPS cell lines.
iPS line Medium Isolated colonies Established lines Efficiency
T1 (Fischer) N2B27/3i 155 6 3.8
T13 (Fischer) N2B27/3i 108 4 3.7
T13 (Fischer) N2B27/2i 40 15 37.5
E9 (Wistar) N2B27/2i 96 35 36.5
E14 (Wistar) N2B27/2i 18 4 22.2
doi:10.1371/journal.pone.0055170.t002
Rat iPS Cells without Viral Vectors
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(Clontech) coding region with long oligonucleotides using Phusion
Polymerase (Finnzymes). The mCherry translational start codon
was mutated from ATG to GTG, which also encodes the C-
terminal valine of the NLS to avoid translation of untagged
protein. The cassette was inserted between the NcoI and XhoI
restriction sites of pTriEx-HTNC (Addgene plasmid 13763, [26])
to generate pTriEx-Cherry. Expression in bacteria and purifica-
tion of NLS-Cherry-9R was performed according to [26]. Protein
transduction was performed with iPS cells on MEF feeder cells, in
suspension culture in 15 ml Falcon tubes, or in monolayer culture
on 2% Geltrex using 5 mM recombinant protein for 4 or 24 h.
Results
Generation of Doxycycline-dependent Rat iPS Cells
Two cell types from two rat strains were used to generate iPS
cells: adipose tissue-derived mesenchymal stem cells (rADMSC)
and ear fibroblasts (rEF) from Fischer and Wistar rats. Cells were
cotransfected with the reprogramming vector pReproII-attB and
the wC31 integrase expression vector pCAG-C31Int(NLS) (see
Figure 1A). pReproII-attB contains the minimal bidirectional
doxycycline-inducible promoter Pbi-1 [27], which directs expres-
sion of the murine reprogramming factors Oct4, c-Myc, Klf4 and
Sox2 as bicistronic mRNAs. The pReproII-attB vector also
encodes other necessary components of the Tet-On system: the
tetracycline-controlled transactivator rtTA2(S)-M2 and the tetra-
cycline-regulated repressor tTSKRAB under the control of the
constitutive CAG promoter [28], [22], [29]. An attB site is also
included to facilitate wC31 integrase-mediated integration at
pseudo-attP sites in the host genome [30], [31].
We found that double nucleofection (on days 0 and 3) resulted
in more efficient generation of rat iPS cells than a single
nucleofection step. Six days after initial nucleofection, cells were
transferred onto a feeder layer in N2B27-3i medium containing
doxycycline to induce expression of the exogenous reprogramming
factors. Colonies with rat ES/iPS cell-like morphology appeared 8
to 10 days after doxycycline induction. Individual colonies were
manually picked between day 14 and 20, transferred to multiwell
plates and expanded. The outline scheme is shown in Figure 1B. A
total of 37 iPS cell lines were established from Fischer rat
ADMSCs and EFs and 18 lines from Wistar rat ADMSCs and
EFs. Results and efficiencies are summarized in Table 1. At this
stage, growth of each line relied on continued presence of
doxycycline and expression of exogenous reprogramming factors.
Analysis of Vector Integration
We used a non-viral vector equipped with an attB phage wC31
integrase recognition site (see Figure 1A) to facilitate integration
into the rat genome. Three preferred integration sites, so called
pseudo-attP sites rps1, rps2 and rps3, have been identified in the
rat genome [24].
Two Fischer iPS cell lines, T1 and T13, and two Wistar iPS cell
lines, E9 and E14, were analyzed by Southern blot to determine
the number of vector integrations in each. We identified two (T1,
T13) or four (E9, E14) integrations as shown in Figure 1C. To
determine whether these were at known pseudo-attP sites (rps) we
performed PCR analysis similar to that previously described [24].
wC31-mediated integration can occur in either forward or reverse
orientation, we therefore analyzed integration in both directions.
None were found at sites rps1 or rps3. Screening of rps2 sites
revealed integration in reverse orientation in lines T1 and T13.
The wild-type fragment spanning rps1, 2 and 3 was amplified in all
lines, indicating that the rps2 integration in lines T1 and T13 had
occurred at one allele (see Figure 1D). Sequence analysis of the
PCR fragment from lines T1 and T13 confirmed vector
integration into the rps2 site on chromosome 1q41. The other
integrations did not occur at the known three sites.
Generation of Doxycycline-independent Rat iPS Cell Lines
Two doxycycline-dependent iPS lines from Fischer ADMSCs
(T1, T13), and two from Wistar EF (E9, E14) were used for further
experiments. Initially iPS cells were cultured in N2B27-3i medium
with doxycycline for 14 days, then doxycycline induction
withdrawn. 263 colonies were isolated between days 14 and 24
after doxycycline removal from lines T1 and T13 and expanded in
N2B27-3i medium (see Figure 1B). 10 doxycycline-independent
iPS cell lines were established. This rather low efficiency (,4%)
led us to investigate alternative culture media. Twelve media
compositions were tested, these differed in the presence or absence
of Knockout Serum Replacement, inhibitor combinations, addi-
tion of Thiazovivin, ROCK inhibitor Y27632 or ascorbic acid (see
Table S4). Best results were obtained with N2B27-2i medium,
which differs from N2B27-3i in that it lacks ALK5 inhibitor A83-
01 and Knockout Serum Replacement. Using N2B27-2i, 15 of 40
(37.5%) colonies from Fischer line T13 and 39 of 114 colonies
from Wistar lines E9 and E14 (22.2% to 36.5%) were established
as doxycycline-independent iPS cell lines, representing a consid-
erable improvement over N2B27-3i. Detailed results and efficien-
cies are shown in Table 2. This, together with reduced
spontaneous differentiation and a more stable ES-like cell
morphology led us to use N2B27-2i medium for further culture.
Examples of cell morphology before reprogramming and after
doxycycline removal are shown in Figure 2A. Comparison of our
reprogramming efficiencies with rat iPS cells generated by viral
methods or by wC31 integrase-based reprogramming of murine
and human cells is shown in Table 3.
Expression of Exogenous Reprogramming Factors in
Doxycycline-dependent and -Independent Rat iPS Cell
Lines
We compared the expression of exogenous reprogramming
factors in the parental doxycycline-dependent rat iPS cell lines
(T1, T13, E9 and E14) in the presence of doxycycline, with six
doxycycline-independent subclones (T1/64, T13/3, E9/19, E9/
54, E14/5 and E14/15). Quantitative RT-PCR specific for
bicistronic Oct4-T2A-c-Myc or Sox2-T2A-Klf4 mRNAs showed
high exogenous factor expression in doxycycline-dependent lines,
Figure 3. Differentiation analysis of rat iPS cells. (A) Representative images of embryoid bodies (EBs) generated by suspension or colony EB
culture of lines T1/64 and E9/54 (106magnification). (B) RT-PCR analysis of T1/64 and E9/54 before and after EB based differentiation. Marker genes
for undifferentiated cells and differentiated derivatives of the three embryonic germ layers are as indicated. GAPDH control, water (W) and reverse
transcriptase enzyme (-RT) negative controls are indicated. (C) Immunocytochemical analysis of undifferentiated and differentiated rat iPS cells from
line T1/64 and E9/54 (106magnification). Markers for three germ layers were: albumin, sarcomeric a-actinin, bIII-tubulin. Nuclei were stained with
Hoechst. (D) Teratoma analysis. First column: Macroscopic images of one teratoma. Second column: H&E stained section showing endoderm derived
intestinal epithelium (top and bottom). Third column: H&E stained section showing mesoderm derivatives cartilage (top and bottom) and blood
vessels (bottom); and endoderm derivatives pancreatic tissue and intestinal epithelium (bottom). Fourth column: H&E stained section showing
ectoderm derivatives keratinized epidermis (top) and neural rosettes (bottom) (206magnification).
doi:10.1371/journal.pone.0055170.g003
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and 100- to 1,000,000-fold less in doxycycline-independent
subclones, see Figure 2D. This, together with an undifferentiated
morphology, indicated successful activation of the endogenous
pluripotency program.
Pluripotency Markers, Methylation Status and Karyotype
Analysis
We analyzed the expression of endogenous pluripotency marker
genes in two doxycycline-independent iPS cell lines: Fischer iPS
line T1/64 and Wistar iPS line E9/54. Oct4, Sox2, Nanog, FGF4
and Rex1 expression was analyzed by RT-PCR using rat-specific
primers. As Figure 2E shows, both iPS lines expressed these key
markers, while the source rADMSC and rEF cells did not. Both
lines also expressed the stem cell marker alkaline phosphatase (AP)
(see Figure 2B). Immunocytochemical analysis revealed that both
lines T1/64 and E9/54 were Oct4,SSEA1 positive and SSEA4
negative (see Figure 2B), which accords with previous descriptions
of rat ES and iPS cells [5], [8], [7]. Source cells were Oct4,
SSEA1, SSEA4 and AP negative (see Figure 2B).
Another hallmark of successful reprogramming is the demeth-
ylation of promoter regions of key pluripotency genes such as Oct4
and Nanog [32], [33]. We performed bisulfite sequencing of a
206 bp region (21495 to 21290) of the rat Oct4 promoter, which
contains 7 CpG sites [8]. In rADMSCs 6 to 7 CpG sites were
methylated, in rEFs 3 to 5 were methylated, whereas none were
methylated in iPS cell lines T1/64 and E9/54 (see Figure 2C).
This further confirmed reprogramming to a self-sustaining
pluripotent state.
We then performed karyotype analysis. Rat iPS cell line T1/64
showed a normal karyotype (2n = 42) in 80% metaphase spreads
examined. Line E9/54 was mostly polyploid. Diploid metaphase
spreads were analyzed and 20% showed normal karyotype
(2n= 42). These results accord with previous reports of rat ES
and iPS cell karyotypic variability [5], [6], [10], [15].
Differentiation of Rat iPS Cells in vitro and in vivo
Rat iPS cell differentiation was investigated in vitro by embryoid
body (EB) formation, and in vivo by teratoma formation in NSG
mice.
EB procedures developed for mouse ES cells [34] were
unsuccessful when applied unmodified to rat iPS cells. Rat iPS
cells cultured as single cells in suspension in medium containing
serum typically died after two days. We therefore developed an
alternative protocol. Cell suspensions were cultured in 50%
DMEM+, 50% N2B27-2i medium (EB medium I) for two days,
during which cells spontaneously aggregated. Medium was
Figure 4. Rat iPS cells in monolayer culture. (A) Attachment of rat iPS cells to coated tissue culture plates (106magnification). Plates were
coated with gelatin, fibronectin, collagen I, Matrigel, laminin or Geltrex. (B) Immunocytochemical analysis of rat iPS cell lines T1/64 and E9/54 cultured
on Geltrex, Matrigel, laminin or feeder cells for Oct4, SSEA1 and SSEA4 (106magnification). (C) Alkaline phosphatase staining of rat iPS cell lines T1/64
and E9/54 cultured on Geltrex, Matrigel, laminin or feeder cells (106magnification).
doi:10.1371/journal.pone.0055170.g004
Figure 5. DNA transfection and protein transduction of iPS cells. (A) Rat iPS cells showing GFP expression after transfection with
Lipofectamine 2000, Nanofectin (feeder-free monolayer culture) or Nucleofection. Untransfected cells were used as a negative control (106
magnification). (B) Rat iPS cells showing red fluorescence after transduction (4 h or 24 h) with NLS-Cherry-9R protein on feeder cells, in suspension or
feeder-free monolayer culture (206 and 106magnification).
doi:10.1371/journal.pone.0055170.g005
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changed to 70% DMEM+, 30% N2B27-2i (EB medium II) for two
days, then to DMEM+. Under these conditions rat iPS cells
reliably generated EBs (see Figure 3A). These findings are
consistent with reports that the GSK3b inhibitor CHIR99021 is
necessary for EB formation in rat ES cells [14]. We also developed
a technique, termed colony EB culture, that produced EBs with
high efficiency by taking advantage of the poor attachment of
undifferentiated rat iPS cells. Colonies 100 to 200 mm in diameter
were flushed off the feeder layer, resuspended in EB medium I and
cultured further as described above. This improved cell survival
(see Figure 3A), but produced EBs of diverse size.
We used colony EB culture with iPS cell line T1/64 and E9/54
and analyzed expression of genes characteristic of the three
embryonic germ layers by RT-PCR. After 8 days in suspension,
mesodermal (Nkx2.5, Flk1, SM22a), endodermal (Sox17, Gata4,
Gata6) and ectodermal (Nestin, NCAM) marker genes were
expressed, whereas Oct4 and Nanog expression was markedly
reduced (see Figure 3B). EBs were allowed to attach to gelatin-
coated plates, cultured for 12 days in medium containing serum
(DMEM+) and outgrowths examined. Immunocytochemical
analysis revealed differentiation to neurons as detected by
expression of bIII-tubulin, cardiomyocytes by sarcomeric a-
actinin, and hepatocytes by albumin, see Figure 3C. Undifferen-
tiated rat iPS cells did not express these markers, see Figure 3C.
The ability of rat iPS cells to generate differentiated tissues
within a teratoma was tested by injecting undifferentiated T1/64
cells into NSG immunodeficient mice. All injection sites generated
tumors up to 1.5 cm in diameter after 25 days. One was sectioned
and examined histologically. Staining with H&E revealed complex
organized structures and identifiable derivatives of the three
embryonic germ layers, including intestinal epithelium and
pancreatic cells (endoderm), cartilage and blood vessels (meso-
derm), also neural rosettes and epidermis (ectoderm), as shown in
Figure 3D. These data demonstrate that our rat iPS cells are
pluripotent.
Rat iPS Cells in Feeder-free Monolayer Culture
We investigated whether our rat iPS cells could be cultured as
monolayers without feeder cells. This would allow more control
over differentiation than EB based methods. Rat iPS and ES cells
are known to attach poorly even on feeder cells, but success has
been reported with rat ES cells on laminin coated plates [6]. We
compared laminin, bovine gelatin, collagen type I, fibronectin, and
the Engelbreth-Holm-Swarm tumor basement membrane extracts
Matrigel and Geltrex. No attachment was observed on gelatin,
collagen type I or fibronectin. In contrast, rat iPS cells attached to
Matrigel, Geltrex or laminin coated plates, proliferated and
formed colonies of morphologically undifferentiated cells (see
Figure 4A). Cells on Matrigel, Geltrex and laminin were fixed after
5 to 7 days and characterized by immunocytochemistry and
alkaline phosphatase (AP) staining. Similar to iPS cells on feeder
layers, they were positive for Oct4, SSEA1, AP and negative for
SSEA4 (see Figure 4B and 4C). Immunocytochemical detection of
differentiation markers albumin, bIII-tubulin and sarcomeric a-
actinin was negative, confirming that rat iPS cells on Matrigel,
Geltrex and laminin remain undifferentiated (see Figure S1).
Cumulative cell numbers and population doubling times were
compared between cells grown on Matrigel, Geltrex, laminin and
on feeder cells (see Figure S2). No differences were observed after
48 h, but after 96 h iPS cell numbers were higher on Matrigel,
Geltrex and laminin (mean 1.756106 cells per well) than on
feeders (1.176106 cells per well). Doubling times based on
exponential cell growth were 16.4 h (laminin), 19.8 h (Matrigel),
20.6 h (Geltrex) and 27.8 h (feeders).
Transfection and Protein Transduction of Rat iPS Cells
The ability of pluripotent cells to undergo genetic and other
manipulations in culture is fundamental to their practical
usefulness. We therefore assessed rat iPS cells for their ability to
undergo DNA transfection by three different methods: Nanofec-
tion and Lipofection of feeder-free monolayers and Nucleofection
of suspended cells. A GFP reporter plasmid was used as a
convenient indicator. Transient transfection efficiency determined
after 24 h showed more than 10% of cells transfected with
Lipofectamine 2000, ,9% with Nanofectin and ,4% with
Nucleofection, see Figure 5A. Cells were replated onto feeders
two days after transfection and no change in iPS morphology was
observed. Lipofectamine 2000 and Nucleofection slightly reduced
cell viability, but Nanofectin had no detectable effect.
We investigated if our rat iPS cells can be efficiently transduced
with recombinant proteins. This would for example allow direct
delivery of recombinases such as Cre, or transcription factors for
directed differentiation without genetic manipulation. A cell
penetrating red fluorescent protein, NLS-Cherry-9R, was gener-
ated by fusing the mCherry coding region to a protein
transduction domain consisting of 9 arginine residues (9R) and
the SV40 Large-T nuclear localization signal (NLS) [35], [36],
[37], [38]. NLS-Cherry-9R was expressed in bacteria, and rat iPS
cells transduced for either 4 or 24 hours on feeder cells, in
suspension or as feeder-free monolayers. As shown in Figure 5B,
24 hours transduction in suspension or monolayer culture resulted
in up to 80% red fluorescent cells.
These experiments demonstrate that our rat iPS cells are
amenable to genetic and non-genetic manipulation, enabling the
use of a wide range of molecular tools.
Discussion
We describe a significant advance in rat iPS technology, the
efficient generation of rat iPS cells using a single non-viral vector
that allows tight control over reprogramming factor expression.
The established iPS lines were self-sustaining and had activated
the endogenous pluripotency program. Methods have been
developed to improve rat iPS cell viability and successful
generation of differentiated iPS derivatives in vitro. Teratoma
formation in vivo and differentiation in vitro demonstrate pluripo-
tency. Our rat iPS cells can be cultured as monolayers free of
feeder cells, at least for short periods, and readily undergo DNA
transfection and protein transduction.
To date rat iPS cells have been generated using retroviral or
lentiviral vectors based on the original breakthrough by Yamanaka
[7], [8], [15], [16], [9]. However, the viral approach has
shortcomings. To circumvent the need for multiple viral infections,
Hamanaka et al. (2011) developed a polycistronic inducible
lentiviral system that encodes all factors [39]. This enables control
of factor expression and introduces individual factors in equivalent
ratio. Nevertheless lentiviral transduction still requires high viral
titers for efficient transduction and viral production must be under
strict biosafety conditions.
Our plasmid based reprogramming approach avoids these
issues. A single vector contains the reprogramming factors under
doxycycline-inducible control and all necessary Tet-On regulatory
components. Because transfected DNA integrates into the host
genome less frequently than infecting retro- or lentiviruses [40], an
attB site was included to facilitate wC31 integrase-mediated
integration [41], [24]. Cotransfection of the reprogramming vector
with wC31 integrase enabled efficient generation of doxycycline-
dependent rat iPS cells. Direct comparison of the efficiency of our
approach with that of others is not always straightforward because
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many reports base their calculations on different parameters, such
as the number of stable iPS cell lines, alkaline phosphatase positive
colonies, SSEA1 positive colonies or cell morphology (see Table 3).
Reprogramming efficiency, calculated as the number of stable iPS
cell lines obtained relative to starting cell number, reveals a range
of 0.00174% to 0.014% in previous reports [7], [15], [42], [43].
We obtained 0.0027% to 0.0028% for doxycycline-dependent and
0.005% to 0.0078% for doxycycline-independent rat iPS cells.
This compares favorably with methods based on viral vectors.
Generation of self-sustaining rat iPS cells after doxycycline
removal depended on the culture medium. N2B27-2i medium was
superior to N2B27-3i at this stage, highlighting a negative
influence of the ALK5 inhibitor A83-01 or Knockout Serum
Replacement on iPS generation. This indicates that one or both
reduces colony formation, maintenance and expansion and
accords with previous reports that N2B27-2i conditions are
suitable for rat ES and iPS culture [5], [6], [15]. Addition of
Thiazovivin, ROCK inhibitor Y27632 or ascorbic acid did not
increase efficiency compared to N2B27-3i or N2B27-2i.
Traditional methods of EB formation such as hanging drops, or
aggregation in single cell suspension are difficult with rat
pluripotent stem cells [5], [14], [15]. Our colony EB method is
a significant improvement that reduces cell death and allows
reliable generation of EBs without the need for additional small
molecules such as the ROCK inhibitor Y27632 [14].
We also investigated appropriate conditions for feeder-free
monolayer culture and found that rat iPS cells attached to
Matrigel, Geltrex and laminin substrates. Previously only attach-
ment to laminin has been shown [6]. Rat iPS cells grown on
Matrigel, Geltrex or laminin maintained expression of Oct4,
SSEA1 and alkaline phosphatase. Cumulative cell numbers were
similar on the three substrates but slight differences were observed
in population doubling time. The increased range of coating
matrices opens new possibilities for feeder-free iPS cell culture,
transfection and cell differentiation without EB formation.
Future applications such as gene targeting require genetic
manipulation, preferably free of feeder cells. The established
monolayer conditions enabled transfection with Lipofectamine
2000 and Nanofectin, resulting in up to 10% transfection
efficiency, useful alternatives to the most commonly used
techniques, nucleofection and electroporation [5], [44], [45], [11].
Directed differentiation of iPS cells may require the addition of
inductive transcription factors for only a short time. Transduction
of protein rather than DNA is a useful means of achieving this, and
also leaves the genome unaltered. Our rat iPS cells can be
efficiently transduced with recombinant proteins in suspension or
monolayer culture. Rat iPS cells can thus be cultured on feeder
cells, transfected/transduced in monolayer culture and then
transferred back onto feeder cells as required.
We have demonstrated that rat iPS cells can be generated by a
safe and simple non-viral approach. Improved methods for
differentiation and the use of coating substrates for monolayer
culture will facilitate derivation of many different cell types from
rat iPS and ES cells, a goal not yet achieved. These will provide
valuable resources for diverse biomedical research.
Supporting Information
Figure S1 Immunocytochemical analysis of undifferentiated rat
iPS cells. Immunocytochemical analysis of rat iPS cell lines T1/64
and E9/54 cultured on Geltrex, Matrigel, laminin or feeder cells
for albumin, sarcomeric a-actinin (Actinin) and bIII-tubulin (TuJ1)
(106magnification).
(TIF)
Figure S2 Cumulative cell number of rat iPS cells on different
matrices. Cell numbers on day 0, 2 and 4 of rat iPS cells cultured
on Geltrex, Matrigel, laminin or feeder cells. Total cell number
per well of a 12 well plate was determined in triplicate.
(TIF)
Table S1 Oligonucleotides for RT-PCR and qRT-PCR.
(DOC)
Table S2 Oligonucleotides for integration analysis.
(DOC)
Table S3 Oligonucleotides for bisulfite sequencing and Southern
blot analysis.
(DOC)
Table S4 Different culture media for rat iPS cells.
(DOC)
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